ConductScience.org, home

Paper378754

Treatment of cirrhosis with colchicine. A double-blind randomized trial.

Kershenobich D and 5 others. Gastroenterology, 1979. Cited by 135 papers, by iCite.

Cite this record

ConductScience Library. Treatment of cirrhosis with colchicine. A double-blind randomized trial. Papers, record 378754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/378754

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of cirrhosis with colchicine. A double-blind randomized trial.
PubMed
Journal
Gastroenterology
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
135
iCite
Relative citation ratio, by iCite
5.87
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kershenobich DD
2Uribe MM
3Suárez GIG I
4Mata JMJ M
5Pérez-Tamayo RR
6Rojkind MM

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ColchicineMajor topic
Liver CirrhosisMajor topic
Adult
Aged
Alkaline Phosphatase
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Liver
Male
Middle Aged
Placebos
Proline
Prospective Studies
Serum Albumin

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.

PMIDTitleJournalYearIn PapersSource
39927511Colchicine for the primary prevention of cardiovascular events.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/39927511PubMed
32054504Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials.Arthritis Res Ther2020https://conductscience.org/library/papers/32054504PubMed
28381952The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process.Gastroenterol Hepatol (N Y)2006https://conductscience.org/library/papers/28381952PubMed
26816301Colchicine for prevention of cardiovascular events.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/26816301PubMed
25278689Alcoholic liver disease: treatment.World J Gastroenterol2014https://conductscience.org/library/papers/25278689PubMed
24133661KASL clinical practice guidelines: management of alcoholic liver disease.Clin Mol Hepatol2013https://conductscience.org/library/papers/24133661PubMed
18985799Role of cannabinoids in chronic liver diseases.World J Gastroenterol2008https://conductscience.org/library/papers/18985799PubMed
15846629Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.Cochrane Database Syst Rev2005https://conductscience.org/library/papers/15846629PubMed
9046020Effect of chronic colchicine administration on the myocardium of the aging spontaneously hypertensive rat.Mol Cell Biochem1997https://conductscience.org/library/papers/9046020PubMed
8375627Hepatic fibrosis--current concepts of pathogenesis and therapy.Gastroenterol Jpn1993https://conductscience.org/library/papers/8375627PubMed
8244117Reversal of carbon tetrachloride induced changes in microviscosity and lipid composition of liver plasma membrane by colchicine in rats.Gut1993https://conductscience.org/library/papers/8244117PubMed
7038110A new look at cirrhosis.J R Coll Physicians Lond1982https://conductscience.org/library/papers/7038110PubMed
6235989In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine.Clin Exp Immunol1984https://conductscience.org/library/papers/6235989PubMed
6225583Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever.Clin Exp Immunol1983https://conductscience.org/library/papers/6225583PubMed
6217006Correction of a suppressor cell deficiency in four patients with familial Mediterranean fever by in vitro or in vivo colchicine.Clin Exp Immunol1982https://conductscience.org/library/papers/6217006PubMed
6129179Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trial.Gut1982https://conductscience.org/library/papers/6129179PubMed
4044871Structural aspects of the liver in patients with biliary disease and portal hypertension.J Clin Pathol1985https://conductscience.org/library/papers/4044871PubMed
3781173Effects of antifibrotic substances on pancreatic fibrosis following acute necrotizing pancreatitis.Gastroenterol Jpn1986https://conductscience.org/library/papers/3781173PubMed
2375835Accidental overdose of insufflated colchicine.Drug Saf1990https://conductscience.org/library/papers/2375835PubMed
2081478Interaction of alcohol with other drugs and nutrients. Implication for the therapy of alcoholic liver disease.Drugs1990https://conductscience.org/library/papers/2081478PubMed

See all 21 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/378754

GET https://conductscience.org/api/papers/v1/378754/cited_by?page=2